ALICIA FAULKNER: Open Payments
NPI 1114550621 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 54 payments from 19 companies in 2025. Trend: 2023 $1,421 · 2024 $2,278 · 2025 $1,349
Food & beverage: $1,349
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 20 | $397 |
| AstraZeneca Pharmaceuticals LP | 9 | $394 |
| Regeneron Healthcare Solutions, Inc. | 4 | $89 |
| Verona Pharma, Inc. | 3 | $55 |
| Tactile Systems Technology Inc | 1 | $47 |
| Viatris Specialty LLC | 2 | $45 |
| Corcept Therapeutics | 2 | $45 |
| Neurocrine BioSciences, Inc. | 1 | $37 |
| Novo Nordisk Inc | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
Products named: BREZTRI, NUCALA, TRELEGY ELLIPTA, DUPIXENT, AIRSUPRA, TEZSPIRE, Ohtuvayre, Flexitouch Plus.
Industry payments across TX — which companies pay providers there.
